Nimbolide is an Anticancer Agent for Triple-negative Breast Cancer Research
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. It accounts for approximately 15%–20% of newly diagnosed cases with poor clinical outcomes. Recently, phytochemicals have garnered significant attention…